CARAFATE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Carafate, and what generic alternatives are available?

Carafate is a drug marketed by Abbvie and is included in two NDAs.

The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the sucralfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Carafate

A generic version of CARAFATE was approved as sucralfate by TEVA on March 29^th, 1996.

Try a Trial

Summary for CARAFATE

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	14
Clinical Trials:	4
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CARAFATE
Drug Sales Revenues:	Drug sales revenues for CARAFATE
What excipients (inactive ingredients) are in CARAFATE?	CARAFATE excipients list
DailyMed Link:	CARAFATE at DailyMed

Drug patent expirations by year for CARAFATE

Recent Clinical Trials for CARAFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Thompson Cancer Survival Center	Phase 3
LCMC Health	N/A
Ochsner Health System	N/A

See all CARAFATE clinical trials

Pharmacology for CARAFATE

Drug Class	Aluminum Complex

Anatomical Therapeutic Chemical (ATC) Classes for CARAFATE

A02BX	Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02	DRUGS FOR ACID RELATED DISORDERS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for CARAFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	CARAFATE	sucralfate	SUSPENSION;ORAL	019183-001	Dec 16, 1993	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Abbvie	CARAFATE	sucralfate	TABLET;ORAL	018333-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CARAFATE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	CARAFATE	sucralfate	TABLET;ORAL	018333-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CARAFATE

See the table below for patents covering CARAFATE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
France	1500571	Nouveaux composés aluminiques de polysulfates de disaccharides et leur procédé de préparation	⤷ Try a Trial
France	6064		⤷ Try a Trial
Germany	1568346		⤷ Try a Trial
Belgium	895077		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for CARAFATE

Recent Clinical Trials for CARAFATE

Pharmacology for CARAFATE

Anatomical Therapeutic Chemical (ATC) Classes for CARAFATE

Make Better Decisions: Try a trial or see plans & pricing